ARTICLE | Company News
Vicuron's dalbavancin delayed
May 12, 2005 12:45 AM UTC
Vicuron (MICU; NMerc:MICU) said FDA extended the PDUFA date for dalbavancin to treat complicated skin and soft tissue infections (cSSTIs) by three months to Sept. 21. The original PDUFA date for the o...